Fathia Gibril

8.0k total citations
74 papers, 5.6k citations indexed

About

Fathia Gibril is a scholar working on Epidemiology, Neurology and Oncology. According to data from OpenAlex, Fathia Gibril has authored 74 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Epidemiology, 37 papers in Neurology and 33 papers in Oncology. Recurrent topics in Fathia Gibril's work include Neuroendocrine Tumor Research Advances (67 papers), Neuroblastoma Research and Treatments (37 papers) and Lung Cancer Research Studies (24 papers). Fathia Gibril is often cited by papers focused on Neuroendocrine Tumor Research Advances (67 papers), Neuroblastoma Research and Treatments (37 papers) and Lung Cancer Research Studies (24 papers). Fathia Gibril collaborates with scholars based in United States, Italy and Malaysia. Fathia Gibril's co-authors include Robert T. Jensen, David Venzon, Jeffrey A. Norton, José Serrano, John L. Doppman, Douglas L. Fraker, H. Richard Alexander, Stephan U. Goebel, Paolo L. Peghini and B Termanini and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Annals of Internal Medicine.

In The Last Decade

Fathia Gibril

73 papers receiving 5.4k citations

Peers

Fathia Gibril

EPIDE

ONCOL

NEURO

SURGE

MB

Peter Stålberg Sweden

Brian R. Untch United States

Samira M. Sadowski United States

Patricia Niccoli France

Claes Juhlin Sweden

Patricia Niccoli‐Sire France

Andreas Raffel Germany

Julien Hadoux France

Kjell E. Öberg Sweden

Karin Frank‐Raue Germany

Peter Stålberg Sweden

Fathia Gibril

1.2k ×0.2

EPIDE

1.1k ×0.3

ONCOL

728 ×0.2

NEURO

1.4k ×1.8

SURGE

437 ×0.7

MB

Citations per year, relative to Fathia Gibril Fathia Gibril (= 1×) peers Peter Stålberg

Countries citing papers authored by Fathia Gibril

Since Specialization

Citations

This map shows the geographic impact of Fathia Gibril's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fathia Gibril with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fathia Gibril more than expected).

Fields of papers citing papers by Fathia Gibril

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fathia Gibril. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fathia Gibril. The network helps show where Fathia Gibril may publish in the future.

Co-authorship network of co-authors of Fathia Gibril

This figure shows the co-authorship network connecting the top 25 collaborators of Fathia Gibril. A scholar is included among the top collaborators of Fathia Gibril based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fathia Gibril. Fathia Gibril is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Norton, Jeffrey A., David Venzon, Marc J. Berna, et al.. (2008). Prospective Study of Surgery for Primary Hyperparathyroidism (HPT) in Multiple Endocrine Neoplasia-Type 1 and Zollinger-Ellison Syndrome. Annals of Surgery. 247(3). 501–510. 99 indexed citations

2.

Skarulis, Monica C., William F. Simonds, Lee S. Weinstein, et al.. (2004). Multiple Endocrine Neoplasia Type 1 Variant with Frequent Prolactinoma and Rare Gastrinoma. The Journal of Clinical Endocrinology & Metabolism. 89(8). 3776–3784. 40 indexed citations

3.

Norton, Jeffrey A., H. Richard Alexander, Douglas L. Fraker, et al.. (2004). Does the Use of Routine Duodenotomy (DUODX) Affect Rate of Cure, Development of Liver Metastases, or Survival in Patients With Zollinger-Ellison Syndrome?. Annals of Surgery. 239(5). 617–626. 114 indexed citations

4.

Gibril, Fathia & Robert T. Jensen. (2003). Diagnostic uses of radiolabelled somatostatin receptor analogues in gastroenteropancreatic endocrine tumours. Digestive and Liver Disease. 36. S106–S120. 75 indexed citations

5.

Norton, Jeffrey A., H. Richard Alexander, Douglas L. Fraker, et al.. (2003). Possible Primary Lymph Node Gastrinoma: Occurrence, Natural History, and Predictive Factors. Annals of Surgery. 237(5). 650–659. 103 indexed citations

6.

Goebel, Stephan U., Michiko Iwamoto, Mark Raffeld, et al.. (2002). Her-2/neu expression and gene amplification in gastrinomas: correlations with tumor biology, growth, and aggressiveness.. PubMed. 62(13). 3702–10. 44 indexed citations

7.

Abou‐Saif, Alaa, Jun-Yi Lei, Thomas J. McDonald, et al.. (2001). A new cause of Zollinger–Ellison syndrome: Non–Small cell lung cancer. Gastroenterology. 120(5). 1271–1278. 17 indexed citations

8.

Gibril, Fathia, Alaa Abou‐Saif, Praveen K. Roy, et al.. (2001). CASE REPORT: Retained Gastric Antrum Syndrome. Digestive Diseases and Sciences. 46(3). 610–617. 14 indexed citations

9.

Corleto, Vito D., Bruno Annibale, Fathia Gibril, et al.. (2001). Does the widespread use of proton pump inhibitors mask, complicate and/or delay the diagnosis of Zollinger–Ellison syndrome?. Alimentary Pharmacology & Therapeutics. 15(10). 1555–1561. 55 indexed citations

10.

Azzoni, Cinzia, et al.. (2000). Intramucosal cysts in the gastric body of patients with Zollinger-Ellison syndrome. Human Pathology. 31(2). 140–148. 14 indexed citations

11.

Serrano, José, Stephan U. Goebel, Paolo L. Peghini, et al.. (2000). Alterations in the p16^INK4a/CDKN2A Tumor Suppressor Gene in Gastrinomas. The Journal of Clinical Endocrinology & Metabolism. 85(11). 4146–4156. 98 indexed citations

12.

Roy, Praveen K., David Venzon, Alaa Abou‐Saif, et al.. (2000). Zollinger-Ellison Syndrome: Clinical Presentation in 261 Patients. Medicine. 79(6). 379–411. 228 indexed citations

13.

Goebel, Stephan U., José Serrano, Fang Yu, et al.. (1999). Prospective study of the value of serum chromogranin A or serum gastrin levels in the assessment of the presence, extent, or growth of gastrinomas. Cancer. 85(7). 1470–1483. 54 indexed citations

14.

Goebel, Stephan U., José Serrano, Fang Yu, et al.. (1999). Prospective study of the value of serum chromogranin A or serum gastrin levels in the assessment of the presence, extent, or growth of gastrinomas. Cancer. 85(7). 1470–1483. 2 indexed citations

15.

Gibril, Fathia & Robert T. Jensen. (1999). Comparative analysis of diagnostic techniques for localization of gastrointestinal neuroendocrine tumors.. PubMed. 70(5-6). 509–22. 28 indexed citations

16.

Jensen, Robert T., Fathia Gibril, & B Termanini. (1999). Definition of the role of somatostatin receptor scintigraphy in gastrointestinal neuroendocrine tumor localization.. PubMed. 70(5-6). 481–500. 26 indexed citations

17.

Norton, Jeffrey A., Douglas L. Fraker, H. Richard Alexander, et al.. (1999). Surgery to Cure the Zollinger–Ellison Syndrome. New England Journal of Medicine. 341(9). 635–644. 330 indexed citations

18.

Termanini, B, Fathia Gibril, Reynolds Jc, et al.. (1997). Value of somatostatin receptor scintigraphy: A prospective study in gastrinoma of its effect on clinical management. Gastroenterology. 112(2). 335–347. 151 indexed citations

19.

Gibril, Fathia, John L. Doppman, Richard L. Chang, et al.. (1996). Metastatic gastrinomas: localization with selective arterial injection of secretin.. Radiology. 198(1). 77–84. 40 indexed citations

20.

Orbuch, Murray, et al.. (1996). Prolonged hypergastrinemia does not increase the frequency of colonic neoplasia in patients with Zollinger-Ellison syndrome. Digestive Diseases and Sciences. 41(3). 604–613. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact